Compared to WT, AD astrocytes have a 2.68 log2FC increase in Gfap expression; after APC treatment, Gfap became significantly downregulated with a 2.52 log2FC decrease in expression (Figure 2D). This evidence concerns the gene GFAP and Alzheimer disease.